{
    "Trade/Device Name(s)": [
        "Vision BioSystems Estrogen Receptor Clone 6F11 (ER 6F11)"
    ],
    "Submitter Information": "Vision BioSystems, Inc.",
    "510(k) Number": "K060227",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYA"
    ],
    "Summary Letter Date": "May 11, 2006",
    "Summary Letter Received Date": "May 12, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry Reagents and Kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "immunology"
    ],
    "Analyte(s)": [
        "Estrogen receptor"
    ],
    "Specimen Type(s)": [
        "Formalin fixed, paraffin embedded tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Ventana Medical Systems NexES",
        "BenchMark Immunohistochemistry Staining Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry",
        "Monoclonal antibody staining",
        "Light microscopy"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Immunohistochemical analysis"
    ],
    "Submission Type(s)": [
        "Antibody",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Vision BioSystems Estrogen Receptor Clone 6F11 (ER 6F11) monoclonal antibody for qualitative immunohistochemical detection of estrogen receptor in tissue sections",
    "Indications for Use Summary": "Intended for laboratory use to qualitatively identify estrogen receptor antigen in sections of formalin fixed, paraffin embedded tissue as an aid in the management, prognosis, and prediction of therapy outcome in breast cancer",
    "fda_folder": "Hematology"
}